miRNAs have been implicated in neuroblastoma metastasis [52], MYCN regulation [66,67], and cell differentiation [68]; thus they may serve as novel therapeutic targets, especially in high-risk, MYCN-amplified patients [53,69,70]. This evidence concerns the gene MYCN and neuroblastoma.